Société Medicenna Therapeutics Corp.
Actions
MDNA
CA58490H1073
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,38 CAD | +3,03% | +22,05% | +466,67% |
Métier
Nombre d'employés: 16
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | - | 01/10/11 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 02/02/15 |
David Hyman
DFI | Director of Finance/CFO | - | 14/02 |
Delphine Davan
IRC | Investor Relations Contact | - | 14/08/23 |
Minh To
PRN | Corporate Officer/Principal | - | 14/08/23 |
Eamonn Peters
PRN | Corporate Officer/Principal | - | 14/08/23 |
Evelyn Pau
PRN | Corporate Officer/Principal | - | 14/08/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 24/09/19 |
Albert Beraldo
BRD | Director/Board Member | - | 22/11/16 |
Fahar Merchant
CEO | Chief Executive Officer | - | 02/02/15 |
Founder | - | 01/10/11 | |
Jack Geltosky
BRD | Director/Board Member | 78 | 30/09/20 |
John Sampson
BRD | Director/Board Member | - | 23/09/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 74 778 857 | 48 558 694 ( 64,94 %) | 0 | 64,94 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+466,67% | 121 M | |
+26,28% | 48,09 Md | |
-3,99% | 40,43 Md | |
+47,07% | 40,62 Md | |
-6,20% | 28,36 Md | |
+6,36% | 24,89 Md | |
-21,47% | 19,01 Md | |
+27,58% | 12,09 Md | |
-2,75% | 11,8 Md | |
-2,02% | 11,88 Md |
- Bourse
- Actions
- Action MDNA
- Société Medicenna Therapeutics Corp.